+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 10 Actively Recruiting clinical trials

O

Actively Recruiting

Diffuse large B-cell lymphoma DLBCL is the most common and aggressive subtype of non-Hodgkin lymphoma NHL, affecting many patients with rapid tumor growth and symptoms depending on tumor location. This observational study aims to understand the clinical characteristics, treatment patterns, and access to new therapies for patients with DLBCL in the Middle East and Africa region, including both newly diagnosed and relapsed or refractory cases. Participants are grouped into two cohorts those who are newly diagnosed and eligible for treatment, and those who have relapsed or are refractory after at least one prior therapy. The study does not involve experimental treatments but collects information on how patients are treated in real-world settings and explores access to innovative therapies. During the study, patient demographics, disease characteristics, risk profiles, and treatment patterns are documented over 22 months. Researchers will gather data through reviews of medical records and clinical information without administering treatments. The primary goal is to describe first-line and subsequent treatment approaches and to understand patient access to novel therapies for DLBCL.

All AgesAll Genders
21 locations
A

Actively Recruiting

Hepatocellular carcinoma HCC is a common and serious cancer worldwide, often linked to cirrhosis caused by hepatitis B or C viruses and steatotic liver disease. This research focuses on understanding the causes, patient and tumor characteristics, treatments, and outcomes of HCC in adults across various countries in the Middle East and North Africa region, where the disease burden is significant. Differences in healthcare resources and access in these countries affect diagnosis and treatment outcomes. The study collects and reviews existing medical records of adult patients diagnosed with HCC between 2015 and 2023 in the MENA region. It examines details such as patient demographics, tumor features, risk factors, and treatment methods used. This observational study uses secondary data collection without administering any new treatments or interventions. Participants will have their clinical information, laboratory tests, imaging results, and treatment histories analyzed from medical records. The research team will assess outcomes like overall survival and progression-free survival over an eight-year period. Data completeness and follow-up for at least six months are required for inclusion. The study aims to improve understanding of HCC management and outcomes in this region through detailed data review.

All AgesAll Genders
17 locations
C

Actively Recruiting

Researchers are collecting detailed information about patients with venous thromboembolism VTE to improve understanding of this condition, especially in groups often excluded from clinical trials such as pregnant women, elderly patients, and those with severe health issues. This observational registry aims to provide data that can help reduce death rates, recurrences of blood clots, bleeding problems, and arterial events related to VTE. This study gathers clinical details about each patient, including other health conditions, and tracks the type, dose, duration, and results of antithrombotic treatments over the first three months. The registry is accessible online to assist doctors in managing complex cases by comparing patient profiles and identifying those at higher risk of complications. Participants clinical status and treatment outcomes are recorded, focusing on recurrence of VTE, bleeding events, and mortality over a three-year period. The information supports the creation of predictive scores to help healthcare providers identify patients at higher risk. The study started in 2001 and plans to continue until 2027, with ongoing data collection and follow-up.

All AgesAll Genders
305 locations
O

Actively Recruiting

This observational study focuses on adults diagnosed with cancer who are currently receiving anticancer treatments such as chemotherapy, hormone therapy, immunotherapy, or targeted therapies. The research aims to understand how common dietary supplement use is among cancer patients, the patterns of their use, and how these supplements might interact with anticancer medications. Researchers seek to explore the tolerance profile of these supplements and any potential drug interactions that may arise. Participants will complete a detailed, face-to-face questionnaire about their use of dietary supplements, including the types of supplements taken, how often and how long they have been used, reasons for taking them, and any perceived side effects. The study collects information on the participants anticancer treatments and other clinical data from medical records to analyze the relationship between supplement use and cancer therapies. Throughout the study, participants provide sociodemographic details and report on supplement use and possible adverse effects. Researchers will assess potential drug-supplement interactions using artificial intelligence tools at enrollment or during a single study visit. The main measurements are the prevalence of supplement use, tolerance, and drug interaction profiles. Participation involves completing the questionnaire and allowing access to medical records, with the study expected to continue until the end of 2027.

Age: 18Years +All Genders
1 location
R

Actively Recruiting

Researchers are evaluating how robotic training compares to conventional rehabilitation for patients with adhesive capsulitis of the shoulder, also known as frozen shoulder. This study explores how new technologies like robotics and virtual reality might improve functional recovery and brain reorganization during rehabilitation. The trial aims to better understand the benefits of these approaches for restoring shoulder function and reducing pain. Participants are randomly assigned to one of two groups one group receives robotic training that includes continuous passive mobilization and therapy using the Armeo Spring device, while the other group undergoes standard rehabilitation sessions with a physiotherapist. Both treatments focus on improving shoulder movement and autonomy. The study does not use any masking or blinding methods. During the study, participants will have their shoulder function measured using the Shoulder Pain and Disability Index SPADI at multiple time points up to 12 months. Pain levels and active and passive range of motion will also be assessed regularly. This allows researchers to monitor progress and compare outcomes between the two rehabilitation methods. The total duration of participation may last about a year, with evaluations at 3 weeks, 6 weeks, 3 months, 6 months, 9 months, and 12 months.

Age: 18Years +All GendersPhase Not Applicable
1 location
S

Actively Recruiting

Researchers are studying the quality of primary healthcare for patients with arterial hypertension in Morocco, focusing on the diseases prevalence, types, complications, and treatment personalization. This observational cohort study aims to improve understanding and management of hypertension by comparing current data with past results and other North African countries. The study highlights key aspects like timely care, accessibility, and adherence to clinical guidelines. The study uses a remote electronic registry to collect anonymous medical data from both primary care and hospital settings. Trained investigators will standardize blood pressure measurements to reduce errors. Data gathered will include clinical details, treatments, complications, anthropometric measurements, blood pressure readings using validated devices or ambulatory monitoring, and metabolic assessments such as blood glucose and cholesterol levels. Cardiovascular complications will also be tracked. The follow-up period targets one year to observe complications related to hypertension. Participants aged 18 and older with diagnosed hypertension will provide informed consent before inclusion. Researchers will analyze the prevalence and geographic spread of hypertension, its various types, and associated complications at the study start. Data collection includes physical measurements, laboratory tests, and complication records. The study will compare findings to previous years and other countries to identify care gaps and progress. The total participation spans from initial inclusion through a one-year follow-up to monitor outcomes and inform better prevention and treatment strategies.

Age: 18Years +All Genders
5 locations
R

Actively Recruiting

Researchers are evaluating whether early endovascular thrombectomy EVT combined with standard anticoagulation improves outcomes compared to anticoagulation alone in adults with severe cerebral venous sinus thrombosis CVST. This multicenter, randomized, open-label trial focuses on patients aged 18 to 65 presenting within 14 days of symptom onset with imaging-confirmed CVST and markers of severity, aiming to address the lack of strong evidence for EVT in this condition, especially in the Middle East, North Africa, and South Asia regions. Participants are randomly assigned to one of two groups the intervention arm receiving EVT within 24 hours plus standard anticoagulation, and the control arm receiving anticoagulation alone. EVT techniques include mechanical thrombectomy, aspiration, or balloon-assisted methods. Anticoagulation consists of intravenous heparin or low-molecular-weight heparin followed by oral anticoagulants for 3-12 months. The study spans approximately 42 months, with 18 months for enrollment and 12 months follow-up for the last patient. Participants will undergo assessments at 30, 90, and 180 days after randomization, including clinical evaluations like the modified Rankin Scale and NIH Stroke Scale, quality of life questionnaires, cognitive testing, and imaging at 90 days. Researchers will monitor functional independence at 12 months as the primary outcome, along with secondary outcomes such as recanalization rates, mortality, clinical improvement timing, quality of life, cognitive function, and seizure frequency. Safety is overseen by an independent board with interim analyses planned throughout enrollment.

Age: 18Years - 65YearsAll GendersPhase Not Applicable
14 locations
E

Actively Recruiting

Researchers are investigating whether adding lumbopelvic postural rehabilitation to pelvic floor muscle training PFMT improves urinary incontinence symptoms in women compared to PFMT alone. The study focuses on women aged 18 to 65 with urinary incontinence, assessing changes in symptom severity, pelvic floor muscle strength, patient-reported improvement, and quality of life. This clinical trial is randomized and evaluates the effectiveness of combining two rehabilitation approaches in managing urinary incontinence. Participants will be randomly assigned to one of two groups for 12 weeks. The experimental group receives PFMT three times per week along with two weekly sessions of lumbopelvic postural rehabilitation using posturography, which includes stability and mobility exercises for the lumbopelvic area. The control group performs PFMT alone three times per week, including supervised sessions at the hospital and home exercises, focusing on pelvic floor muscle contractions in different positions. During the study, researchers will assess outcomes at the start, 6 weeks, and 12 weeks. Measurements include the International Consultation on Incontinence Questionnaire for urinary incontinence severity, pelvic floor muscle strength, urinary symptom profiles, patient global impression of improvement, and quality of life impact questionnaires. The study includes supervised and home-based training, with monitoring of symptom changes and muscle strength to evaluate treatment effects over the 12-week period.

Age: 18Years - 65YearsFEMALEPhase Not Applicable
1 location
T

Actively Recruiting

Cardiovascular diseases are the leading cause of death worldwide and are increasing in prevalence in Morocco. Researchers are conducting a 10-year follow-up study of adults aged 40 and older who were screened for cardiovascular risk between 2010 and 2012 by the All with heart Association in the Greater Casablanca region. The study aims to evaluate long-term cardiovascular outcomes and develop a risk score specific to the Moroccan population to improve prevention and patient care. This observational study involves following participants who were part of the initial screening campaign, with no interventions applied. Data on cardiovascular events such as deaths, heart attacks, and strokes will be collected through phone calls, WhatsApp, or SMS with participants or their families. Statistical analyses will be used to identify key risk factors and create a predictive model tailored to Morocco. Participants will be contacted periodically to gather follow-up information on their cardiovascular health. The study will measure the incidence of major and minor cardiovascular events over ten years and work on validating a Morocco-specific cardiovascular risk score. The total participation duration is 10 years, with data collection relying on remote communication methods. Safety monitoring includes tracking cardiovascular-related outcomes and deaths.

Age: 40Years +All Genders
2 locations
E

Actively Recruiting

This research aims to assess whether giving intravenous tranexamic acid around the time of surgery reduces blood loss and maintains blood hemoglobin levels in men aged 50 and older undergoing transurethral resection of the prostate TURP under spinal anesthesia. The trial is a prospective, randomized, quadruple-blind, placebo-controlled study designed to evaluate perioperative bleeding and recovery in patients with benign prostatic hyperplasia. Participants are randomly assigned to receive either tranexamic acid at a dose of 10 mgkg or a matching placebo intravenously about 30 minutes before TURP surgery. The study compares blood loss during surgery measured by hemoglobin in irrigation fluid and hemoglobin levels 24 hours after surgery. Secondary outcomes include transfusion needs, surgery duration, catheterization length, hospital stay, adverse events, and economic impacts. During the trial, participants will undergo standardized spinal anesthesia and receive the assigned treatment before surgery. Researchers will monitor blood loss during the operation and measure hemoglobin levels afterward. Follow-up includes tracking recovery markers, transfusions, urinary catheter duration, hospital length of stay, and any complications up to 30 days post-surgery. The study duration encompasses surgery and hospital discharge monitoring, with data collection for safety and health-economic evaluation.

Age: 50Years +MALEPhase 4
1 location